Abstract  Description  Claims  Drawing  Search report  Cited references 

WO2010081173A   [0010]  [0108]  [0114]  [0127] 
WO2004044011A   [0031]  [0167] 
WO2005040229A   [0031]  [0167] 
WO2002032925A   [0031]  [0167] 
WO1995001937A   [0031]  [0167] 
WO2002020565A   [0031]  [0167] 
WO2003029462A   [0031]  [0167] 
WO2008016854A   [0031]  [0167] 
US6248516B1   [0037] 
WO2015143414A   [0038] 
US20110123527A1   [0038] 
WO2009125825A   [0083] 
WO2013128194A   [0108]  [0114]  [0127] 
WO2009025846A   [0108]  [0114]  [0127] 
WO2015116933A   [0129] 
WO2015048329A   [0129] 
WO2016118629A   [0129] 
WO2016179257A   [0129] 
WO2016179285A   [0129] 
WO2016179335A   [0129] 
WO2016179003A   [0129] 
WO2016046778A   [0129] 
WO2016014974A   [0129] 
US20160289324A   [0129] 
US20160311903A   [0129] 
WO2010115998A   [0274]  [0289]  [0355]  [0359] 
WO2015046554A   [0330]  [0331] 

Monoclonal antibody successes in the clinic   [0011] 
The therapeutic antibodies market to 2008   [0011] 
Monoclonal antibodies: versatile platforms for cancer immunotherapy   [0011] 
Differential responses of human tumor cell lines to anti-pl 85HER2 monoclonal antibodies   [0011] 
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas   [0011] 
Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies   [0011] 
Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective   [0011] 
Antibody-drug conjugates: targeted drug delivery for cancer   [0011] 
Teaching antibodies to engage T-cells for cancer therapy   [0011] 
T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells   [0011] 
Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma   [0011] 
Ipilimumab in the treatment of melanoma   [0011] 
IPILIMUMAB - A NOVEL IMMUNOMODULATING THERAPY CAUSING AUTOIMMUNE HYPOPHYSITIS: A CASE REPORT AND REVIEW   [0011] 
The Japanese experience with biologic therapies for rheumatoid arthritis   [0011] 
Ann. Rheum. Dis.   [0011] 
Antibody engineering for the development of therapeutic antibodies   [0011] 
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index   [0011] 
Probody therapeutics for targeting antibodies to diseased tissue   [0011] 
Proc. Natl. Acad. Sci. USA   [0019] 
Annu. Rev. Biophys. Biomol. Struct.   [0019] 
Proc. Natl. Acad. Sci. U.S.A.   [0019] 
Kuby Immunology   [0025] 
J. Mol. Biol.   [0026] 
Sequences of Proteins of Immunological Interest   [0026]  [0029] 
J. Mol. Biol.   [0026] 
J Biol Chem.   [0033] 
Methods in Molecular Biology   [0039] 
Biochimica et Biophysica Acta - Proteins and Proteomics   [0039] 
Journal of Applied Microbiology   [0039] 
Journal of Biomolecular Screening   [0039] 
Journal of Biological Chemistry   [0039] 
AIDS   [0039] 
J. Immunol.   [0042] 
Methods in Molecular Biology   [0047] 
J. Mol. Biol.   [0053]  [0054] 
Methods Enzymol.   [0054] 
Antibodies: A Laboratory Manual   [0056] 
J Clin Invest.   [0091] 
Antibodies   [0091]  [0272] 
J Pharm Sci.   [0092] 
J Inflamm (Lond)   [0108] 
Nat Rev Immunol.   [0108] 
Nat Rev Drug Discov.   [0108] 
Respir Res.   [0108] 
Dis Model Mech.   [0108] 
Biochim Biophys Acta   [0108] 
Nat Rev Cancer.   [0109] 
PNAS   [0110] 
Nat Rev Drug Discov.   [0110] 
Nature Biotechnology   [0127] 
PNAS   [0129] 
Biochemical Journal   [0129] 
Beilstein J Nanotechnol.   [0129] 
J. Mol. Biol.   [0146] 
Mol Cell Biol.   [0205] 
Current protocols in Molecular Biology edit   [0205]  [0206] 
Nat Biotechnol.   [0237] 
Nucleic Acids Res.   [0237] 
Proc Natl Acad Sci U S A.   [0237] 
Proc Natl Acad Sci U S A.   [0237] 
Protein Eng Des Sel.   [0237] 
Proc Natl Acad Sci U S A.   [0237] 
MAbs   [0237] 
Methods Mol Biol.   [0237] 
The Chinese-German Journal of Clinical Oncology   [0264] 
Blood   [0266]  [0272] 
J. Immunol.   [0278] 
J. Immunol. Methods.   [0310]  [0323] 
J. Immunol. Methods   [0310]  [0323] 
Biotechnol. Prog.   [0310]  [0323] 
Mol. Cell Proteomics   [0310]  [0323] 
Journal of Molecular Biology   [0333] 
J. Immunol. Methods   [0333]